apollo
logo
0Login
Introducing Our Latest Arrival!
Romiset 250 mcg Injection 1's

Romiset 250 mcg Injection 1's

Prescription drug
 Trailing icon
Consult Doctor

Manufacturer/Marketer

Alkem Laboratories Ltd

Consume Type

PARENTERAL

Return Policy

Not Returnable

Expires on or after

Jan-25

for this medicine

About Romiset 250 mcg Injection

Romiset 250 mcg Injection belongs to the class of 'platelet-stimulating agents' primarily used to treat chronic immune thrombocytopenia in adults who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. Immune thrombocytopenia, often called idiopathic thrombocytopenic purpura (ITP), is an immune disorder characterised by low platelet counts.

Romiset 250 mcg Injection contains 'Romiplostim,' which is a thrombopoietin receptor agonist that functions similarly to thrombopoietin. Romiset 250 mcg Injection promotes platelet formation by activating the thrombopoietin receptor. Thereby, Romiset 250 mcg Injection helps treat immune thrombocytopenia effectively.

Romiset 250 mcg Injection will be administered by the healthcare professional. In some cases, Romiset 250 mcg Injection may cause common side effects like headache, joint pain, dizziness, trouble sleeping, muscle tenderness or weakness, pain in the arms and legs and indigestion. These side effects may vary individually. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

Notify your doctor if you have allergic reactions to Romiset 250 mcg Injection or other medications. You must inform your doctor if you have leukaemia (blood or bone marrow cancer), bleeding or clotting disorders, or heart, kidney, or liver problems. Romiset 250 mcg Injection is not recommended during pregnancy unless indicated by the doctor. Romiset 250 mcg Injection may make you dizzy; hence drive or operate machinery only when you are alert. Romiset 250 mcg Injection is not recommended for use during breastfeeding.

Uses of Romiset 250 mcg Injection

Treatment of Immune thrombocytopenia or idiopathic thrombocytopenic purpura (ITP)

Medicinal Benefits

Romiset 250 mcg Injection contains 'Romiplostim' which belongs to the class of 'thrombopoietin receptor agonists' used to treat low blood platelet count in patients with immune thrombocytopenia. Romiset 250 mcg Injection promotes platelet formation by activating the thrombopoietin receptor. Thereby, Romiset 250 mcg Injection helps treat immune thrombocytopenia effectively.

Directions for Use

Romiset 250 mcg Injection will be administered by a healthcare professional. Your doctor decides the dose and duration based on your medical condition and response to the treatment.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Romiset 250 mcg Injection

  • Joint pain (arthralgia)
  • Dizziness
  • Insomnia (inability to sleep)
  • Muscle pain (myalgia)
  • Pain in extremities
  • Abdominal pain
  • Shoulder pain
  • Dyspepsia (indigestion)
  • Paresthesia (tingling or pricking sensation)
  • Headache
  • Sore throat

Drug Warnings

Before beginning Romiset 250 mcg Injection, notify your doctor if you have had any allergic reactions to Romiset 250 mcg Injection or any other medications. You must notify your doctor if you have blood or bone marrow cancer (leukaemia), bleeding or clotting disorders, heart, kidney, or liver problems. Romiset 250 mcg Injection is not recommended during pregnancy unless indicated by the doctor. Romiset 250 mcg Injection may make you dizzy hence do not attempt to drive or operate machinery until you are physically stable and mentally alert. Romiset 250 mcg Injection should never be used to normalize platelet counts; Romiset 250 mcg Injection should only be used in ITP patients whose thrombocytopenia and clinical condition increase the risk of bleeding. Romiset 250 mcg Injection is not recommended for use during breastfeeding.

Drug Interactions

Drug-Drug Interactions: Romiset 250 mcg Injection may interact with anti-cancer medication (e.g. carfilzomib, ibritumomab) and medication used to treat myasthenia gravis (e.g. efgartigimod alfa).

Drug-Food Interactions: No interactions found/established.

Drug-Disease Interactions: Romiset 250 mcg Injection may interact with disease conditions like leukaemia, liver or kidney impairment.

Drug-Drug Interactions Checker List

  • EFGARTIGIMOD ALFA
  • CARFILZOMIB
  • IBRITUMOMAB

Habit Forming

No

Diet & Lifestyle Advise

  • Eating papaya is the greatest natural therapy for increasing platelet count; you can also use a blend of papaya leaves.
  • A high protein diet, which includes lean meat, chicken, crab, turkey, beef, and fish, can help improve platelet count.
  • Include iron-rich foods such as pomegranate, beetroot, green leafy vegetables, carrots, raisins, oranges, peanuts, kidney beans, and black-eyed peas.
  • Platelet counts can be increased by eating foods high in vitamin C, such as guava, black currant, red pepper, kiwi, green peppers, orange, strawberries, pineapple, peas, mango, grapefruit, and broccoli.
  • Exercise on a regular basis to keep your body and mind healthy.
  • Smoking and consuming alcohol should be avoided.
  • To reduce the risk of bleeding, avoid activities such as contact sports and the use of sharp objects such as nail cutters and razors.

Disease/Condition Glossary

Immune thrombocytopenia: It is an immune disorder characterised by low platelet counts and abnormal blood clotting. It happens when the immune system destroys its own platelets by mistake. Immune thrombocytopenia symptoms include easy bruising, bleeding from the gums and nose, blood in the urine and stools, heavy menstruation, and pinpoint-sized reddish-purple patches on the lower thighs.

bannner image

Alcohol

Caution

You are recommended not to consume alcohol along with Romiset 250 mcg Injection to avoid unpleasant side effects.

bannner image

Pregnancy

Caution

Romiset 250 mcg Injection is not recommended in pregnancy unless indicated by the doctor. Please consult your doctor if you are pregnant or planning to conceive.

bannner image

Breast Feeding

Unsafe

Breast-feeding must be avoided during treatment with Romiset 250 mcg Injection. Please consult your doctor if you have any concerns.

bannner image

Driving

Caution

Romiset 250 mcg Injection may cause dizziness. Hence, it is recommended not to drive or operate machinery until you are mentally alert.

bannner image

Liver

Caution

Romiset 250 mcg Injection is not recommended particularly if you have a history of chronic liver disease/conditions. Please consult your doctor if you have any concerns

bannner image

Kidney

Caution

Limited information was available for the usage of Romiset 250 mcg Injection in patients suffering from kidney illness. Please consult your doctor if you have any concerns. Your doctor will prescribe only if the benefits outweigh the risks.

bannner image

Children

Caution

Romiset 250 mcg Injection is not recommended for children less than one year of age.

Country of origin

India

Manufacturer/Marketer address

Alkem Laboratories Limited, Devashish Building, Alkem House, Senapati Bapat Road, Lower Parel, Mumbai - 400 013.
Other Info - ROM0151

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Romiset 250 mcg Injection belongs to the class of 'platelet-stimulating agents' primarily used to treat chronic immune thrombocytopenia in adults who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.
Romiset 250 mcg Injection contains Romiplostim, which promotes platelet formation by activating the thrombopoietin receptor. Thus Romiset 250 mcg Injection lowers the risk of bleeding episodes in diseases like immune thrombocytopenia and other associated conditions.
Immune thrombocytopenia is an autoimmune disorder in which the immune system misidentifies platelets as foreign bodies and destroys them. It can occur due to a virus, vaccination, or certain drugs. But the origin is unknown in the majority of cases.
Romiset 250 mcg Injection is only advised for patients who have not responded adequately to other treatments such as corticosteroids, immunoglobulins, or splenectomy.
Idiopathic thrombocytopenic purpura is typically diagnosed with blood tests such as complete blood count and antiplatelet-antibody test.
Romiset 250 mcg Injection is not approved to treat thrombocytopenia caused by Myelodysplastic syndrome (MDS) or any other cause of thrombocytopenia apart from chronic ITP.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
icon image

Keep Refrigerated. Do not freeze.Prepaid payment required.

Add to Cart